🔥🔥🔥 JOIN OUR STARTUP AMBASSADOR PROGRAM 🔥🔥🔥
    📣 Spread the news & get a PRO membership 3 months for FREE with all features🚀📈💵500 vouchers left • 3 months free

    EnteraSense

    EnteraSense develops PillSense, an ingestible capsule technology designed to detect upper gastrointestinal bleeding in real-time using advanced optical sensors. The device wirelessly transmits diagnostic data to an external receiver to assist healthcare professionals in the triage process and reduce the need for urgent endoscopies. The company operates under a licensed technology agreement from Brigham and Women’s Hospital and Harvard Medical School to serve the gastroenterology and emergency medicine markets.

    Visit websiteGalway, IrelandFounded 2015
    Healthtech
    Medical Devices
    Diagnostics
    Gastroenterology

    Funding summary

    Total raised
    €3.5M
    Funding rounds
    1

    Investors in EnteraSense

    Investors on record for EnteraSense. Click any investor to view their CAPLINK profile and funding criteria.

    Fundraising for a startup like EnteraSense?

    Explore CAPLINK's investor database of thousands of active VCs and angels.

    Browse investors

    We use cookies to enhance your experience. Read our Privacy Policy